Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 25, 2016, 03:00 ET Neue Forschungsergebnisse bestätigen einen Zusammenhang zwischen häufig vorkommenden Bakterien (einschließlich MRSA) und Ekzemen

Eine neue, im British Journal of Dermatology[1] veröffentlichte Studie hat gezeigt, dass etwa 70 % von Ekzem-Patienten...


Jul 25, 2016, 02:01 ET Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...


Jul 25, 2016, 02:00 ET ONIVYDE® Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall...


Jul 25, 2016, 01:00 ET Araim Pharmaceuticals Obtains Fourth Orphan Designation: ARA 290 Obtains US Orphan Drug Designation for Treatment to Increase Survival and Improve Functioning of Pancreatic Islets Following Transplantation

 Araim Pharmaceuticals, a clinical stage drug development company with a unique platform technology for activating post-injury tissue...


Jul 24, 2016, 08:00 ET Formal Education And Complex Work May Reduce The Negative Effects Of Bad Diet And Cerebrovascular Disease On Cognition

 Researchers from the Wisconsin Alzheimer's Disease Research Center and Wisconsin Alzheimer's Institute today presented new data that suggests...


Jul 22, 2016, 13:43 ET Resverlogix anuncia la dosificación a los primeros dos pacientes en programas renales y huérfanos ampliados

El comienzo de este ensayo de fase 1 farmacocinético (PK) en pacientes con deterioro renal severo es el primero de una serie de ensayos...


Jul 22, 2016, 09:00 ET Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops

 Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable again through its Branded...


Jul 22, 2016, 02:00 ET Valeant Pharmaceuticals Receives Complete Response Letter From The FDA

No Safety or Efficacy Concerns or Additional Clinical Trials Identified for Approval of Latanoprostene Bunod FDA Letter Related to CGMP at Bausch...


Jul 22, 2016, 01:00 ET Amgen And UCB Submit Biologics License Application For Romosozumab To The FDA

 Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced the submission of a Biologics License Application (BLA) to the U.S. Food...


Jul 21, 2016, 14:39 ET ViaCyte Awarded New CIRM Grant to Develop PEC-Direct for High-Risk Type 1 Diabetes

ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM)...


Jul 21, 2016, 14:35 ET Resverlogix Announces Dosing of First Two Patients in Expanded Renal and Orphan Programs

The commencement of this Phase 1 pharmacokinentic (PK) trial in patients with severe renal impairment is the first in a series of planned clinical...


Jul 21, 2016, 12:00 ET Researchers Discover Gene that Controls Regeneration of Injured Muscle by Adult Stem Cells

A key gene enables the repair of injured muscle throughout life. This is the finding of a study in mice led by researchers at NYU Langone Medical...


Jul 21, 2016, 10:17 ET New Research on Treating Stroke, Aneurysms, and Other Life-Threatening Illnesses to be Highlighted at Society of NeuroInterventional Surgery Boston Meeting, July 25-28

 The Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting in Boston will feature new research and best practices in improving...


Jul 21, 2016, 09:05 ET Novan Announces First Patient Dosed in Phase 2 Anti-Fungal Program

Novan, Inc. today announced that the first patient has been dosed in the Company's Phase 2 clinical program to evaluate the efficacy and safety of...


Jul 21, 2016, 09:00 ET DNAtrix Announces Successful Intratumoral Delivery of DNX-2401 via Alcyone's MEMS Cannula for the Targeted Treatment of Recurrent Glioblastoma

DNAtrix, a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer, announced the successful intratumoral...


Jul 21, 2016, 09:00 ET Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With Trastuzumab In Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

 Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced results from a Phase 3 study evaluating efficacy and safety of ABP 980...


Jul 21, 2016, 08:35 ET Tru-D SmartUVC Validated by New Paper on UV Disinfection

 In advance of the publication of the first-ever, randomized clinical trial on UV disinfection, the Benefits of Enhanced Terminal Room...


Jul 21, 2016, 08:30 ET The Scripps Research Institute Leverages Powerful End-to-End DDN Storage to Help Reveal Secrets to New Medical Treatments

 DataDirect Networks (DDN) today announced that The Scripps Research Institute (TSRI), one of the world's largest independent organizations...


Jul 21, 2016, 08:30 ET Study Demonstrates Cardiac Troponin Analysis Can Help Identify Heart Disease Risk and Guide Treatment

 Analysis of the cardiac troponin of more than 4,000 patients with stable ischemic heart disease via single molecule counting technology...


Jul 21, 2016, 08:00 ET Relievant Medsystems, Inc. Receives FDA 510(k) Clearance for INTRACEPT® for the Relief of Chronic Low Back Pain

Relievant Medsystems, Inc., a privately held medical device company pioneering the therapy of nerve ablation within vertebral bodies for the...


Jul 21, 2016, 08:00 ET BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely to the Skin

 BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, will share findings...


Jul 21, 2016, 07:00 ET Shire Launches Pediatric Indication for Immunodeficiency Treatment HyQvia in Europe

HyQvia (Human Normal Immunoglobulin 10% and Recombinant Human Hyaluronidase) is the only subcutaneous IG treatment for primary and certain...


Jul 21, 2016, 07:00 ET LifeBond Receives FDA IDE Approval for LifeSeal GI Surgical Sealant Clinical Trial

LifeBond, a leader in the development of bio-surgical medical devices for tissue repair, announced today that it has received a U.S. Food and...


Jul 21, 2016, 06:30 ET TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients

 Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated...


Jul 21, 2016, 06:20 ET Contego Medical completa el reclutamiento del Paladin Clinical Registry

Contego Medical, LLC anunció hoy que ha terminado el reclutamiento en Europa del...